p53-Dependent transcriptional control of cellular prion by presenilins

Journal of Neuroscience

Volumn 29, Issue 20, 2009, Pages 6752-6760

  Vincent, Bruno ^a   Sunyach, Claire ^a   Orzechowski, Hans Dieter ^b   St George Hyslop, Peter ^c,d   Checler, Frédéric ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c TORONTO WESTERN HOSPITAL   (Canada)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA SECRETASE INHIBITOR; PRESENILIN; PRION PROTEIN; PROTEIN P53;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN METABOLISM; TRANSACTIVATION; TRANSCRIPTION REGULATION;

AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; BRAIN; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; CYCLIN-DEPENDENT KINASE INHIBITOR P19; EMBRYO, MAMMALIAN; ENZYME INHIBITORS; FIBROBLASTS; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, KNOCKOUT; MUTAGENESIS, SITE-DIRECTED; PRESENILINS; PRIONS; PROTEIN STRUCTURE, TERTIARY; RNA, MESSENGER; TRANSFECTION; TRIGLYCERIDES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 66249100230     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0789-09.2009     Document Type: Article

References (53)

1. Aguzzi A, Polymenidou M (2004) Mammalian prion biology: one century of evolving concepts. Cell 116:313-327. (Pubitemid 38167320)
2. Alves da Costa C, Sunyach C, Pardossi-Piquard R, Sévalle J, Vincent B, Boyer N, Kawarai T, Girardot N, St George-Hyslop P, Checler F (2006) Presenilin-dependent γ-secretase-mediated control of p53-associated cell death in Alzheimer's disease. J Neurosci 26:6377-6385.
3. Bellingham SA, Coleman LA, Masters CL, Camakaris J, Hill AF (2009) Regulation of prion gene expression by transcription factors SP1 and MTF-1. J Biol Chem 284:1291-1301.
4. Borellini F, Glazer RI (1993) Induction of Sp 1-p53 DNA-binding heterocomplexes during granulocyte/macrophage colony-stimulating factor-dependent proliferation in human erythroleukemiacell line TF-I. J Biol Chem 268:7923-7928. (Pubitemid 23120371)
5. Brandner S, Isenmann S, Raeber A, Fischer M, Sailer A, Kobayashi Y, Marino S, Weissmann C, Aguzzi A ( 1996) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379:339-343. (Pubitemid 26033075)
6. Büeler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, Prusiner SB, Aguet M, Weissmann C (1992) Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356:577-582.
7. Büeler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C (1993) Mice devoid of PrP are resistant to scrapie. Cell 73:1339-1347. (Pubitemid 23201147)
8. Cao X, Südh of TC (2001) A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293:115-120.
9. Cashman NR, Loertscher R, Nalbantoglu J, Shaw I, Kascsak RJ, Bolton DC, Bendheim PE (1990) Cellular isoform of the scrapie agent protein participates in lymphocyte activation. Cell 61:185-192. (Pubitemid 20134389)
10. Checler F (1999) Presenilins: multifunctional proteins involved in Alzheimer's disease pathology. IUBMB Life 48:33-39. (Pubitemid 29512982)
11. Checler F, Vincent B (2002) Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators. Trends Neurosci 25:616-620. (Pubitemid 35356508)
12. Chen SG, Teplow DB, Parchi P, Teller JK, Gambetti P, Autilio-Gambetti L (1995) Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem 270:19173-19180.
13. Dermaut B, Croes EA, Rademakers R, Van den Broeck M, Cruts M, Hofman A, van Duijn CM, Van Broeckhoven C (2003) PRNP Vall29 homozygosity increases risk for early-onset Alzheimer's disease. Ann Neurol 53:409-412. (Pubitemid 36258648)
14. De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Von Figura K, Van Leuven F (1998) Deficiency of presenilin 1 inhibits the normal cleavage of amyloid precursor protein. Nature 391:387-390. (Pubitemid 28093512)
15. Dovey HF, John V, Anderson JP, Chen LZ, de Saint Andrieu P, Fang LY, Freedman SB, Folmer B, Goldbach E, Holsztynska EJ, Hu KL, Johnson-Wood KL, Kennedy SL, Kholodenko D, Knops JE, Latimer LH, Lee M, Liao Z, Lieberburg IM, Motter RN, et al. (2001) Functional γ-secretase inhibitors reduce β-amyloid peptide levels in brain. J Neurochem 76:173-181. (Pubitemid 32044380)
16. el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B (1992) Definition of a consensus binding site for p53. Nat Genet 1:45-49.
17. Forloni G, Angeretti N, Chiesa R, Monzani E, Salmona M, Bugiani O, Tagliavini F (1993) Neurotoxicity of a prion protein fragment. Nature 362:543-546. (Pubitemid 23113029)
18. Funke-Kaiser H, Theis S, Behrouzi T, Thomas A, Scheuch K, Zollmann FS, Paterka M, Paul M, Orzechowski HD (2001) Functional characterization of the human prion protein promoter in neuronal and endothelial cells. J Mol Med 79:529-535. (Pubitemid 32905550)
19. Gauczynski S, Peyrin JM, Haik S, Leucht C, Hundt C, Rieger R, Krasemann S, Deslys JP, Dormont D, Lasmézas CI, Weiss S (2001) The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J 20:5863-5875. (Pubitemid 33049262)
20. Gualberto A, Baldwin AS Jr (1995) P53 and Sp1 interact and cooperate in the tumor necrosis factor-induced transcriptional activation of the HIV-1. J Biol Chem 270:19680-19683.
21. Hainfellner JA, Wanschitz J, Jellinger K, Liberski PP, Gullotta F, Budka H (1998) Coexistence of Alzheimer-type neuropathology in CreutzfeldtJakob disease. Acta Neuropathol 96:116-122. (Pubitemid 28356523)
22. Heber S, Herms J, Gajic V, Hainfellner J, Aguzzi A, Rülicke T, von Kretzschmar H, von Koch C, Sisodia S, Tremml P, Lipp HP, Wolfer DP, Müller U (2000) Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J Neurosci 20:7951-7963.
23. Herreman A, Serneels L, Annaert W, Collen D, Schoonjans L, De Strooper B (2000) Total inactivation of γ-secretase activity in presenilin-deficient embryonic stem cells. Nat Cell Biol 2:461-462.
24. ARF. Cell 91:649-659.
25. Kanaani J, Prusiner SB, Diacovo J, Baekkeskov S, Legname G (2005) Recombinant prion protein induces rapid polarization and development of synapses in embryonic rat hippocampal neurons in vitro. J Neurochem 95:1373-1386. (Pubitemid 41779262)
26. Lazarini F, Castelnau P, Chermann JF, Deslys JP, Dormont D (1994) Modulation of prion protein expression by growth factors in cultured mouse astrocytes and PC-12 cells. Mol Brain Res 22:268-274. (Pubitemid 24063648)
27. Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR (2008) Physiology of the prion protein. Physiol Rev 88:673-728.
28. MacLeod MC (1993) Identification of a DNA structural motif that includes the binding sites for Sp1, p53 and GA-binding protein. Nucleic Acids Res 21:1439-1447. (Pubitemid 23154376)
29. Mahal SP, Asante EA, Antoniou M, Collinge J (2001) Isolation and functional characterization of the promoter region of the human prion protein gene. Gene 268:105-114. (Pubitemid 32463794)
30. Mangé A, Milhavet O, Umlauf D, Harris D, Lehmann S (2002) PrPdependent cell adhesion in N2a neuroblastoma cells. FEBS Lett 514:159-162. (Pubitemid 34273931)
31. Marambaud P, Chevallier N, Barelli H, Wilk S, Checler F (1997) Proteasome contributes to the α-secretase pathway of amyloid precursor protein in human cells. J Neurochem 68:698-703. (Pubitemid 27044732)
32. Mobley WC, Neve RL, Prusiner SB, McKinley MP (1988) Nerve growth factor increases mRNA levels for the prion protein and the β-amyloid protein precursor in developing hamster brain. Proc Natl Acad Sci U S A 85:9811-9815. (Pubitemid 19027215)
33. Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, Kellermann O (2000) Signal transduction through prion protein. Science 289:1925-1928.
34. Müller T, Meyer HE, Egensperger R, Marcus K (2008) The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics - relevance for Alzheimer's disease. Prog Neurobiol 85:393-406.
35. Pardossi-Piquard R, Petit A, Kawarai T, Sunyach C, Alves da Costa C, Vincent B, Ring S, D'Adamio L, Shen J, Müller U, St Georges-Hyslop P, Checler F (2005) Presenilin-dependent transcriptional control of the Aβ-degrading enzyme neprilysin by intracellular domains of βAPP and APLP. Neuron 46:541-554. (Pubitemid 40797380)
36. Parkin ET, Watt NT, Hussain I, Eckman EA, Eckman CB, Manson JC, Baybutt HN, Turner AJ, Hooper NM (2007) Cellular prion protein regulates β-secretase cleavage of the Alzheimer's amyloid precursor protein. Proc Natl Acad Sci U S A 104:11062-11067. (Pubitemid 47175226)
37. Powers JM, Liu Y, Hair LS, Kascsack RJ, Lewis LD, Levy LA (1991) Concomitant Creutzfeldt-Jakob and Alzheimer's disease. Acta Neuropathol 83:95-98.
38. Prusiner SB (1998) Prions. Proc Natl Acad Sci US A 95:13363-13383.
39. Qin K, Zhao L, Ash RD, McDonough WF, Zhao RY (2009) ATM- mediatedtranscriptional elevation of prion in response to copper-induced oxidative stress. J Biol Chem 284:4582-4593.
40. Rieger R, Edenhofer F, Lasmézas CI, Weiss S (1997) The human 37-kDa laminin receptor precursor interacts with the prion protein in eucaryotic cells. Nat Med 3:1383-1388. (Pubitemid 28011039)
41. Riemenschneider M, Klopp N, Xiang W, Wagenpfeil S, Vollmert C, Müller U, Förstl H, Illig T, Kretzschmar H, Kurz A (2004) Prion protein codon 129 polymorphism and risk of Alzheimer disease. Neurology 63:364-366. (Pubitemid 38971146)
42. Ryan KA, Pimplikar SW (2005) Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain. J Cell Biol 171:327-335. (Pubitemid 41540024)
43. Santuccione A, Sytnyk V, Leshchyns'ka I, Schachner M (2005) Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate P59fyn and to enhance neurite outgrowth. J Cell Biol 169:341-354. (Pubitemid 40656571)
44. Satoh J, Kurohara K, Yukitake M, Kuroda Y (1998) Constitutive and cytokine-inducible expression of prion protein gene in human neuronal cell lines. J Neuropathol Exp Neurol 57:131-139. (Pubitemid 28084275)
45. Scheinfeld MH, Ghersi E, Laky K, Fowlkes BJ, D'Adamio L (2002) Processing of β-amyloid precursor-like protein-1 and -2 by y-secretase regulates transcription. J Biol Chem 277:44195-44201. (Pubitemid 36157850)
46. Spilman P, Lessard P, Sattavat M, Bush C, Tousseyn T, Huang EJ, Giles K, Golde T, Das P, Fauq A, Prusiner SB, Dearmond SJ (2008) A γ-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brains. Proc Natl Acad Sci U S A 105:10595-10600.
47. Sunyach C, Cissé MA, da Costa CA, Vincent B, Checler F (2007) The C-terminal products of cellular prion protein processing, C1 and C2, exert distinct influence on p53-dependent staurosporine-induced caspase-3 activation. J Biol Chem 282:1956-1963.
48. Vincent B, Beaudet A, Dauch P, Vincent JP, Checler F (1996) Distinct properties of neuronal and astrocytic endopeptidase 3.4.24.16: a study on differenciation, subcellular distribution and secretion processes. J Neurosci 16:5049-5059. (Pubitemid 26269665)
49. Vincent B, Paitel E, Frobert Y, Lehmann S, Grassi J, Checler F (2000) Phorbol ester-regulated cleavage of normal prion protein in HEK293 human cells and murine neurons. J Biol Chem 275:35612-35616.
50. Vincent B, Paitel E, Saftig P, Frobert Y, Hartmann D, De Strooper B, Grassi J, Lopez-Perez E, Checler F (2001) The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol-esters-regulated normal cleavage of the cellular prion protein. J Biol Chem 276:37743-37746. (Pubitemid 37384016)
51. Wakabayashi T, De Strooper B (2008) Presenilins: members of the gammasecretase quartets, but part-time soloists too. Physiology 23:194-204.
52. Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, Shahab A, Yong HC, Fu Y, Weng Z, Liu J, Zhao XD, Chew JL, Lee YL, Kuznetsov VA, Sung WK, Miller LD, Lim B, Liu ET, Yu Q, Ng HH, Ruan Y (2006) A global map of p53 transcription-factor binding sites in the human genome. Cell 124:207-219. (Pubitemid 43069320)
53. Wolfe MS, Xia W, Ostaszewski BL, Diehl TA, Kimberly WT, Selkoe DJ (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity. Nature 398:513-517. (Pubitemid 129523589)